Regarding journal club, the first question is–what is the purpose of reading the article? Is it to learn to read and interpret research? Or to understand a clinically-important topic? Or to understand an important and/or controversial study?
My thought is that journal clubs should select one of the following:
1. Practice guidelines
2. High-yield review articles on clinically-important topics
3. Systematic reviews or meta-analyses combining the results of multiple studies on a topic.
4. Single studies that either have had a clinical impact or are very controversial.
Here are some suggestions for papers that may be good for journal club. They are arranged by year of publication and then alphabetically by the first author.
Click on the link in each citation to see the Abstract on PubMed.
Which ones would you recommend? Please make sure to post your thoughts under “Leave a Reply” at the bottom of this page.
For Practice Guidelines, see https://simpleandpractical.com/guidelines
Published in 2019
Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, Arndt T, Bäckers L, Rothe P, Cipriani A, Davis J, Salanti G, Leucht S. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019 Sep 14;394(10202):939-951. doi: 10.1016/S0140-6736(19)31135-3. Epub 2019 Jul 11. Erratum in: Lancet. 2019 Sep 14;394(10202):918. PubMed PMID: 31303314; PubMed Central PMCID: PMC6891890.
Stroup TS, Gerhard T, Crystal S, Huang C, Tan Z, Wall MM, Mathai C, Olfson M. Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia. JAMA Psychiatry. 2019 May 1;76(5):508-515. doi: 10.1001/jamapsychiatry.2018.4489. PubMed PMID: 30785609; PubMed Central PMCID: PMC6495353.
Tiihonen J, Taipale H, Mehtälä J, Vattulainen P, Correll CU, Tanskanen A. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia. JAMA Psychiatry. 2019 May 1;76(5):499-507. doi: 10.1001/jamapsychiatry.2018.4320. PubMed PMID: 30785608; PubMed Central PMCID: PMC6495354.
Published in 2018
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018 Apr 7;391(10128):1357-1366. PubMed PMID: 29477251; PubMed Central PMCID: PMC5889788.
Crawford MJ, Sanatinia R, Barrett B, Cunningham G, Dale O, Ganguli P, Lawrence-Smith G, Leeson V, Lemonsky F, Lykomitrou G, Montgomery AA, Morriss R, Munjiza J, Paton C, Skorodzien I, Singh V, Tan W, Tyrer P, Reilly JG; LABILE study team. The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled Trial. Am J Psychiatry. 2018 Apr 6:appiajp201817091006. [Epub ahead of print] PubMed PMID: 29621901.
Sit DK, McGowan J, Wiltrout C, Diler RS, Dills JJ, Luther J, Yang A, Ciolino JD, Seltman H, Wisniewski SR, Terman M, Wisner KL. Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry. 2018 Feb 1;175(2):131-139. PubMed PMID: 28969438.
Published in 2017
Lupu AM, Clinebell K, Gannon JM, Ellison JC, Chengappa KNR. Reducing Anticholinergic Medication Burden in Patients With Psychotic or Bipolar Disorders. J Clin Psychiatry. 2017 Nov/Dec;78(9):e1270-e1275. PubMed PMID: 29178683.
Stuckelman ZD, Mulqueen JM, Ferracioli-Oda E, Cohen SC, Coughlin CG, Leckman JF, Bloch MH. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis. J Clin Psychiatry. 2017 Jun;78(6):e648-e655. PubMed PMID: 28682529.
Zhu Y, Krause M, Huhn M, Rothe P, Schneider-Thoma J, Chaimani A, Li C, Davis JM, Leucht S. Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses. Lancet Psychiatry. 2017 Sep;4(9):694-705. PubMed PMID: 28736102.
Zimmerman M, Chelminski I, Dalrymple K, Rosenstein L. Principal diagnoses in psychiatric outpatients with borderline personality disorder: Implications for screening recommendations. Ann Clin Psychiatry. 2017 Feb;29(1):54-60. PubMed PMID: 28207916.
Zimmerman M, Multach MD, Dalrymple K, Chelminski I. Clinically useful screen for borderline personality disorder in psychiatric out-patients. Br J Psychiatry. 2017 Feb;210(2):165-166. PubMed PMID: 27908898.
Copyright © 2018 to 2020, Simple and Practical Medical Education, LLC. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.